Treatment

Semaglutide (1 Mg Dose) clinical trials

Active studies that list Semaglutide (1 Mg Dose) as an intervention or treatment.

3active studies

1recruiting now

1countries represented

1largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 1, Phase 2

Type 2 DiabetesCondition

Semaglutide (1 Mg Dose), Sitagliptin (DPP4 inhibitor)Treatment

China1 locations

Second Affiliated Hospital of Guangzhou Medical UniversitySponsor

Updated 2026-01-28 · NCT07374328See eligibility →

Opening soonNot applicable

Type 2 Diabetes Mellitus (T2DM), Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes MelitusCondition

Mazdutide(Dual GLP-1R/GCGR Agonist), Semaglutide (1 Mg Dose)Treatment

Locations pending0 locations

Tianjin Medical UniversitySponsor

Updated 2026-07-20 · NCT07713992See eligibility →

Opening soonNot applicable

Obesity Type 2 Diabetes MellitusCondition

Fecal microbiota transplantation (FMT), Semaglutide (1 Mg Dose)Treatment

China1 locations

Eighth Affiliated Hospital, Sun Yat-sen UniversitySponsor

Updated 2026-05-20 · NCT07599046See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.